JW Pharmaceutical Future Growth

Future criteria checks 3/6

JW Pharmaceutical is forecast to grow earnings and revenue by 13.3% and 10.3% per annum respectively. EPS is expected to grow by 13.2% per annum. Return on equity is forecast to be 22.2% in 3 years.

Key information

13.3%

Earnings growth rate

13.2%

EPS growth rate

Pharmaceuticals earnings growth	31.7%
Revenue growth rate	10.3%
Future return on equity	22.2%
Analyst coverage	Low
Last updated	22 Aug 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

KOSE:A001067 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	947,450	99,050	80,900	120,150	2
12/31/2025	871,750	89,550	74,300	117,750	2
12/31/2024	802,650	78,250	53,500	80,800	2
9/30/2024	736,543	72,893	65,704	95,076	N/A
6/30/2024	742,090	35,136	91,644	120,197	N/A
3/31/2024	755,737	40,621	91,518	122,485	N/A
12/31/2023	748,527	36,489	46,452	87,157	N/A
9/30/2023	736,668	25,076	42,709	76,046	N/A
6/30/2023	722,312	51,278	29,078	58,339	N/A
3/31/2023	701,393	36,949	28,177	51,238	N/A
12/31/2022	684,351	31,892	44,412	56,764	N/A
9/30/2022	660,661	12,130	32,649	46,346	N/A
6/30/2022	639,806	8,930	37,194	50,657	N/A
3/31/2022	620,832	4,584	27,866	41,446	N/A
12/31/2021	606,585	-968	5,222	18,124	N/A
9/30/2021	581,827	-1,190	4,847	19,302	N/A
6/30/2021	569,978	-3,329	22,689	36,349	N/A
3/31/2021	560,407	-8,469	28,086	43,146	N/A
12/31/2020	547,336	-15,241	48,015	63,054	N/A
9/30/2020	516,529	-31,512	65,219	77,881	N/A
6/30/2020	512,402	-33,320	36,132	49,800	N/A
3/31/2020	510,079	-23,341	43,389	56,719	N/A
12/31/2019	511,335	-25,275	42,354	55,531	N/A
9/30/2019	524,767	-9,432	3,533	16,086	N/A
6/30/2019	538,269	-8,270	40,264	51,987	N/A
3/31/2019	536,808	-659	61,987	72,856	N/A
12/31/2018	537,182	8,057	42,829	52,110	N/A
9/30/2018	534,919	9,113	56,378	66,480	N/A
6/30/2018	521,666	12,567	N/A	35,484	N/A
3/31/2018	510,284	2,417	N/A	5,770	N/A
12/31/2017	502,919	-742	N/A	33,450	N/A
9/30/2017	490,656	14,223	N/A	36,480	N/A
6/30/2017	476,290	3,697	N/A	6,678	N/A
3/31/2017	471,517	-11,472	N/A	14,991	N/A
12/31/2016	467,465	-10,934	N/A	6,739	N/A
9/30/2016	460,523	-18,836	N/A	-799	N/A
6/30/2016	452,150	-12,991	N/A	17,745	N/A
3/31/2016	447,417	2,860	N/A	28,884	N/A
12/31/2015	434,352	1,921	N/A	-4,175	N/A
9/30/2015	447,788	1,575	N/A	8,860	N/A
6/30/2015	439,802	1,064	N/A	15,286	N/A
3/31/2015	426,011	-3,378	N/A	-12,885	N/A
12/31/2014	412,791	-2,357	N/A	7,279	N/A
9/30/2014	386,064	-2,651	N/A	6,994	N/A
6/30/2014	386,067	-2,648	N/A	-16,031	N/A
3/31/2014	395,535	3,095	N/A	16,653	N/A
12/31/2013	394,182	2,275	N/A	18,725	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A001067's forecast earnings growth (13.3% per year) is above the savings rate (2.7%).

Earnings vs Market: A001067's earnings (13.3% per year) are forecast to grow slower than the KR market (29.5% per year).

High Growth Earnings: A001067's earnings are forecast to grow, but not significantly.

Revenue vs Market: A001067's revenue (10.3% per year) is forecast to grow faster than the KR market (9.3% per year).

High Growth Revenue: A001067's revenue (10.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: A001067's Return on Equity is forecast to be high in 3 years time (22.2%)